On December 26, 2023, Stephen Betz, Chief Scientific Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), sold 3,000 shares of the company's stock, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles